NLS Pharmaceutics AG
NLS Pharmaceutics AG (NLSP) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · NLSP · as of Jun 8, 2026
Key Statistics
Explore NLS Pharmaceutics AG Data
nlsp stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
nlsp competitorsNLSP
BACK
BCTXW
CELU
CERO
KTTAStock Performance
Full HistoryAbout NLS Pharmaceutics AG
NLS Pharmaceutics AG is a biopharmaceutical firm dedicated to researching and creating treatments for intricate and uncommon conditions affecting the central nervous system. Its primary focus includes…
what is nls pharmaceutics ag · nlsp stock overview · nls pharmaceutics ag company profile · who is nls pharmaceutics ag ceo · nlsp NASDAQ · nls pharmaceutics ag headquarters · nls pharmaceutics ag business segments
About Stock Overview & Key Data
NLS Pharmaceutics AG (NLSP) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 29, 2021. As of the latest trading session, NLSP stock price is $2.91, with a market capitalization of $919,601. The stock has returned -85.94% over the past 12 months and +0.00% year-to-date.
According to 2 Wall Street analysts, the consensus rating for NLS Pharmaceutics AG stock is Buy, with an average 12-month price target of $—. In fiscal year 2024, NLS Pharmaceutics AG reported revenue of — and net income of -$2.0M. For detailed data — including NLS Pharmaceutics AG revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, NLS Pharmaceutics AG (NLSP) stock price is $2.91. The stock is traded on NASDAQ under the ticker symbol NLSP. The 52-week range is $0.76 – $43.40.